Antithrombotics: indications and management

Scottish Intercollegiate Guidelines Network

Although antithrombotics show proven benefit in a range of indications, these drugs are associated with adverse effects, principally abnormal bleeding. In many cases, patients who may gain most from antithrombotic treatment are also those at high risk of bleeding, such as the elderly with comorbidities. The use of combinations of antithrombotics, with inevitable additional bleeding risk, is expanding, for example after percutaneous coronary artery interventions. To maximise benefit over risks, the selection of patients for treatment with antithrombotics and their management should be evidence based.

This Guidelines summary covers antiplatelet therapy, parenteral and oral anticoagulant therapy, and thrombolytic therapy for prophylaxis and treatment in a range of clinical conditions such as atrial fibrillation, peripheral arterial disease, and cerebrovascular disease.

Register to view this page

Log in or register now for FREE in order to:

  • benefit from unlimited access to all pages, including:
    • 180+ guideline summaries
    • 1000+ evidence-based articles
  • review and leave comments on all articles and summaries
  • automatically track your reading and learning via your CPD tracker
  • on-demand webinars presented by leading clinical experts

Registration only takes 2 minutes and it will give you FREE access to all content across:



Log in

Need help? Email us